biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults✦23:35 FDA sets May 2027 decision date for one-time Huntington's gene therapy✦17:48 Women reported less brain fog on a supplement in a study with no placebo✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults✦23:35 FDA sets May 2027 decision date for one-time Huntington's gene therapy✦17:48 Women reported less brain fog on a supplement in a study with no placebo
← All story threadsSTORY THREAD

Kite's new cell therapy for lymphoma.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 29, 2026
    TRIALS PARTLY HALTED AFTER SEVERE NERVE SIDE EFFECTSCompany update · 2 trials

    Gilead partly pauses lymphoma cell therapy trials over nerve side effects

    Two trials of an experimental cell therapy for an aggressive blood cancer were put on partial hold after some patients had serious nerve and brain side effects.